
Dr. Luis Diaz Jr., far left, and Dr. Andrea Cercek, second from right, with patients from the trial. Photo by Richard DeWitt.
Reason #37 to love New York in 2022? Memorial Sloan Kettering Cancer Center.
So says New York Magazine as it celebrates the groundbreaking clinical trial led by Dr. Andrea Cercek and Dr. Luis Diaz Jr. In the small trial, all 14 participants who received six months of immunotherapy for rectal cancer had complete remission without additional treatment. The patients had a specific mismatch repair-deficient tumor mutation, which is thought to occur for 5% to 10% of rectal cancers.
Read more about the trial from MSK’s coverage and the New England Journal of Medicine article.